Clinica Universidad de Navarra, Universidad de Navarra
The implementation of Magnetic Resonance Image Guided Radiotherapy (MRgRT) into a Prostate Cancer Program aims to reproduce the results obtained with state-of-the-art brachytherapy or EBRT with the added advantage of convenience and lack of invasiveness.
Age
18–85
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Patients with low to favorable intermediate-risk prostate cancer as per the NCCN stratification criteria .
No prior radiation therapy to the target areas
Expected patient survival \>5 years
Patient able to undergo a MRI exam
Suboptimal candidates for high-dose therapy such as elderly, frail patients or patients with large volume glands (i.e, \>60cm3) or extensive TURP in the prior 6-12 months should be considered cautionary indications.
Patients with higher risk but low volume disease not candidates for ENI may be treated on an individual basis
You may not be if
Prior radiation therapy to the target areas
Expected patient survival below 5 years
Patient unable to undergo a MRI exam
Clareo Health | MRI-guided Ultrahypofractionated SBRT Prostate Program
